Initial and subsequent response to pneumococcal polysaccharide and protein-conjugate vaccines administered sequentially to adults who have recovered from pneumococcal pneumonia
about
A review of economic evaluations of 13-valent pneumococcal conjugate vaccine (PCV13) in adults and the elderlyPneumococcal Vaccination in High-Risk Individuals: Are We Doing It Right?Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions[Vaccination against pneumococci and influenza. How good is the evidence?].A randomized clinical trial comparing revaccination with pneumococcal conjugate vaccine to polysaccharide vaccine among HIV-infected adults.Protein carriers of conjugate vaccines: characteristics, development, and clinical trials.Adult survivors of invasive pneumococcal disease exhibit defective B cell function.A randomized clinical trial of the immunogenicity of 7-valent pneumococcal conjugate vaccine compared to 23-valent polysaccharide vaccine in frail, hospitalized elderly.The nasal dendritic cell-targeting Flt3 ligand as a safe adjuvant elicits effective protection against fatal pneumococcal pneumonia.Quantitative and Qualitative Antibody Responses to Immunization With the Pneumococcal Polysaccharide Vaccine in HIV-Infected Patients After Initiation of Antiretroviral Treatment: Results From a Randomized Clinical Trial.Is there a potential role for protein-conjugate pneumococcal vaccine in older adults?Immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccine in Chinese healthy population aged >2 years: A randomized, double-blinded, active control, phase III trialGuidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: Joint ICS/NCCP(I) recommendations.Long-term comparative immunogenicity of protein conjugate and free polysaccharide pneumococcal vaccines in chronic obstructive pulmonary disease.Long-term immune responses and comparative effectiveness of one or two doses of 7-valent pneumococcal conjugate vaccine (PCV7) in HIV-positive adults in the era of combination antiretroviral therapy.Association of time since pneumococcal polysaccharide vaccine receipt and CD4 count with antibody response to the 13-valent pneumococcal conjugate vaccine in HIV-infected adultsWhy the recent ACIP recommendations regarding conjugate pneumococcal vaccine in adults may be irrelevant.Superior immune response to protein-conjugate versus free pneumococcal polysaccharide vaccine in chronic obstructive pulmonary disease.Prevention of infectious diseases in older adults through immunization: the challenge of the senescent immune response.Recommended vaccinations for asplenic and hyposplenic adult patientsPneumococcal polysaccharide vaccination for adults: new perspectives for Europe.Preventing pneumococcal disease in the elderly: recent advances in vaccines and implications for clinical practice.Pneumococcal vaccine and opsonic pneumococcal antibody.Age-related immune response to pneumococcal polysaccharide vaccination: lessons for the clinic.Type 19 Pneumococcal Meningitis: A Patient With 75-Year Clinical and Serologic Follow Up, With a Review of the Evolution of Therapy From Antiserum to Sulfonamides to Penicillin.Pneumococcal 13-valent conjugate vaccine for the prevention of invasive pneumococcal disease in children and adults.Management of community-acquired pneumonia in immunocompetent adults: updated Swedish guidelines 2017.Genetic Control of Antibody Responses to Pneumococcal Capsular Polysaccharides.Streptococcus pneumoniae’s Virulence and Host Immunity: Aging, Diagnostics, and Prevention.Cost–effectiveness of vaccinating adults with the 23-valent pneumococcal polysaccharide vaccine (PPV23) in Germany
P2860
Q26999313-CD2F7305-11DE-4DC3-ABB5-46E0AC39E44DQ28070059-D14E5D5D-7CA1-4F35-9783-1C0C4F8B21E3Q28240370-BAAB8763-2BDA-47F9-A03F-D756861967C8Q30395309-5923EE83-24A6-415E-B906-746DAE0B5E62Q34101331-7A1F880E-8D69-4DF7-AF9A-47DC1D403EB2Q34170021-00CDBDE5-544E-4CD5-8DB0-0F650E79268BQ35019937-546FC164-3F85-445C-B45B-78E4C6EE5E91Q35156164-2F3447F3-E9C2-4BF3-AB1F-E1A1B45E4C06Q35328544-CD4B4A7D-45DF-40BE-B021-70735A98F712Q35753485-F10A14FF-7A67-46B3-8065-B00AD1FC5A3DQ36090837-D5136543-1353-4AA2-BE33-4F1C0A2B90A7Q36255735-26FFDCAC-E729-47AC-89FD-2C39DE91AE5FQ36281234-F95F68B9-9D8C-4E9B-A3DE-7974F01865D9Q36379580-C0EBC134-E3BA-4352-9136-E62603D5B9D9Q36523805-B79A4FBC-8320-4219-BCD4-C4BB475926D1Q37197079-14FB2F28-F3D9-42DC-9813-A0EA8A74ADB2Q37309186-D74003EE-492D-47EC-A92B-144FC960716AQ37343744-282EA467-56CB-4B64-A48C-9D655B343F3DQ37461377-3DAAE110-8A84-45B1-BE68-D091257C48FDQ37669423-BA15AE6B-22DB-4948-B777-AE638025D2F7Q37910264-9C300FAB-D076-492A-B7D2-BAB2A84F2920Q38082673-370D4A13-6217-4CB8-B188-D8CEECBA112AQ38105255-1608F157-E9B1-4242-AD13-864397AC64FBQ38255618-9C97B762-99D9-48AB-940A-764F42C5FA6AQ38616396-2B90AE99-7323-4529-A8AB-1B18270953BDQ44398866-4B1BD07E-2C26-4CAC-A328-8ACD20811816Q47627293-64B6C033-B157-4243-9B34-AD29EBA2BDADQ48074819-FCF4E853-3513-4BB3-BE4B-E4A7C757F7CDQ55514832-DF3A5674-8363-4061-9DEA-1358C3F307D5Q58286129-7E55D28E-E563-431E-A135-4EE2E9414B7E
P2860
Initial and subsequent response to pneumococcal polysaccharide and protein-conjugate vaccines administered sequentially to adults who have recovered from pneumococcal pneumonia
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Initial and subsequent respons ...... ed from pneumococcal pneumonia
@ast
Initial and subsequent respons ...... ed from pneumococcal pneumonia
@en
type
label
Initial and subsequent respons ...... ed from pneumococcal pneumonia
@ast
Initial and subsequent respons ...... ed from pneumococcal pneumonia
@en
prefLabel
Initial and subsequent respons ...... ed from pneumococcal pneumonia
@ast
Initial and subsequent respons ...... ed from pneumococcal pneumonia
@en
P2093
P2860
P356
P1476
Initial and subsequent respons ...... ed from pneumococcal pneumonia
@en
P2093
Adriana M Rueda
Daniel M Musher
Edward A Graviss
Maria C Rodriguez-Barradas
P2860
P304
P356
10.1086/591629
P407
P50
P577
2008-10-01T00:00:00Z